Emory Alzheimer's Disease Research Center

埃默里阿尔茨海默病研究中心

• 批准号: 10408030
• 负责人: DAVID WEINSHENKER
• 金额: $ 15.69万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-15 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10408030
• 关键词: Achievement; Address; Advisory Committees; Affect; Alzheimer' s Disease; Alzheimer' s disease related dementia; Alzheimer' s disease therapeutic; American; Area; Behavioral; Biomedical Engineering; Catalogs; Clinical; Clinical Research; Clinical Sciences; Companions; Complement; Data Science; Dementia; Diagnostic; Discipline; Education; Educational Activities; Educational Curriculum; Educational workshop; Environment; Evaluation; Faculty; Fostering; Funding; Future; Generations; Goals; Institution; Laboratories; Lead; Leadership; Mentors; Mentorship; Methodology; Minority; Mission; Molecular; Monitor; Neurosciences; Output; Participant; Pathogenicity; Postdoctoral Fellow; Prevalence; Prevention; Recording of previous events; Research; Research Activity; Research Personnel; Research Support; Research Training; Resources; Scientist; Standardization; System; Teacher Professional Development; Time; Training; Training Programs; Translational Research; Translations; Underrepresented Minority; Universities; Work; career; cohort; education research; education resources; experience; innovation; instrument; meetings; minority investigator; minority trainee; multidisciplinary; next generation; programs; recruit; skills; success; symposium; targeted biomarker; therapeutic target; tool; translational scientist

SUMMARY/ABSTRACT: RESEARCH EDUCATION COMPONENT Alzheimer’s disease (AD) is the most common cause of dementia, affecting more than 5 million Americans. At the same time that the prevalence of AD is increasing, the number of new investigators in the US is decreasing, which may severely hamper our efforts to develop better diagnostic and treatment tools for AD and related dementias (ADRD). The goal of the Research Education Component (REC) of the Goizueta Alzheimer’s Disease Research Center (ADRC) at Emory is to support research educational activities that complement and enhance the training of the future workforce to meet the nation’s biomedical, behavioral and clinical needs in ADRD. We will achieve this goal by identifying and supporting the research education of junior investigators and trainees from diverse backgrounds and disciplines. In Aim 1, REC leadership and mentors will work with these trainees to develop and execute tailored educational plans for new and early stage investigators to advance towards independence in conducting AD-related research. In Aim 2, we will leverage Emory’s wealth of basic and clinical scientists as well as partner Atlanta-area institutions to identify, recruit and support the research training of new/early stage investigators and trainees from diverse backgrounds and disciplines, with special emphasis on URMs, to engage in AD-related research. In Aim 3, the REC leadership and external advisory committee will rigorously monitor and evaluate the trainees, mentors, and the overall program, and implement improvements when necessary. Success of the REC will result in rolling cohorts of new investigators with a focus on diversity to lead the next generation of ADRD research.

摘要/摘要：研究教育部分 阿尔茨海默病 (AD) 是导致痴呆症的最常见原因，影响超过 500 万美国人。 在 AD 患病率不断增加的同时，美国新研究人员的数量也在增加 减少，这可能会严重阻碍我们开发更好的 AD 诊断和治疗工具的努力 相关痴呆症 (ADRD) 戈伊苏埃塔研究教育部分 (REC) 的目标。 埃默里大学阿尔茨海默病研究中心 (ADRC) 将支持以下研究教育活动： 补充和加强对未来劳动力的培训，以满足国家的生物医学、行为和 我们将通过确定和支持初级研究教育来实现 ADRD 的临床需求。 来自不同背景和学科的研究人员和学员 在目标 1 中，REC 领导和导师。 将与这些学员合作，为新阶段和早期阶段制定和执行量身定制的教育计划 在目标 2 中，我们将利用研究人员在 AD 相关研究方面的独立性。 埃默里大学拥有丰富的基础和临床科学家以及亚特兰大地区的合作伙伴机构来识别、招募和 支持来自不同背景的新/早期研究人员和受训人员的研究培训 目标 3 中，REC 领导力参与 AD 相关研究。 外部顾问委员会将对学员、导师和整体进行严格的监督和评估 计划，并在必要时实施改进。 REC 的成功将导致滚动队列。 注重多样性的新研究人员领导下一代 ADRD 研究。